Qingdao Vland Biotech INC. (SHA:603739)
China flag China · Delayed Price · Currency is CNY
12.24
+0.39 (3.29%)
Nov 5, 2026, 3:00 PM CST

SHA:603739 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
150.31244.16248.73239.6213.87311.83
Trading Asset Securities
288.15224.87199.34292.05212.02170.43
Cash & Short-Term Investments
438.45469.02448.07531.64425.89482.27
Cash Growth
-0.07%4.68%-15.72%24.83%-11.69%38.83%
Accounts Receivable
473.51409.27376.58330.26307.72254.31
Other Receivables
38.2241.9728.6825.8332.5136.3
Receivables
511.74460.24405.26356.09347.91298.37
Inventory
226.47226.37188.95205.41173.63157.02
Prepaid Expenses
-01.590.120.130.06
Other Current Assets
40.1722.9825.3130.6821.8434.1
Total Current Assets
1,2171,1791,0691,124969.4971.82
Property, Plant & Equipment
1,4681,5241,5601,5051,260843.51
Long-Term Investments
15.4576.2598.6480.8477.198.59
Goodwill
84.284.284.284.220.2620.26
Other Intangible Assets
139.47126.72131.13139.74135.63131.46
Long-Term Deferred Tax Assets
27.323.5516.9918.0613.6412.03
Long-Term Deferred Charges
1.361.261.471.411.280.37
Other Long-Term Assets
33.8125.5419.1480.57101.57233.72
Total Assets
2,9863,0402,9813,0342,5792,222

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
192.71194.41224.56231.95147.36112.11
Accrued Expenses
30.93116.92102.0991.7674.2672.89
Short-Term Debt
534.1582.87581.63568.97374.22135.93
Current Portion of Long-Term Debt
13.336.1240.0392.88-1
Current Income Taxes Payable
18.98.3410.068.4311.678.95
Current Unearned Revenue
18.1914.2511.5110.677.4913.62
Other Current Liabilities
123.0754.1761.5783.5130.127.83
Total Current Liabilities
931.21,0071,0311,088645.09372.33
Long-Term Debt
49.9259.7913.9662.0614999
Long-Term Unearned Revenue
61.7559.5863.9755.2647.9660.45
Long-Term Deferred Tax Liabilities
2.31.381.463.022.722.88
Other Long-Term Liabilities
1.111.110.150.150.171.52
Total Liabilities
1,0461,1291,1111,209844.93536.18

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
253.03253.03253.03253.03252.44252.08
Additional Paid-In Capital
702.9702.9702.9712.08705.09693.84
Retained Earnings
878.86841.4796.9759.56704.12674.61
Comprehensive Income & Other
-14.93-14.81-15.1-16.38-16.96-16.03
Total Common Equity
1,8201,7831,7381,7081,6451,605
Minority Interest
120.31128.2132.3117.0989.2281.07
Shareholders' Equity
1,9401,9111,8701,8251,7341,686
Total Liabilities & Equity
2,9863,0402,9813,0342,5792,222

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
597.32678.78635.62723.92523.22235.93
Net Cash (Debt)
-158.87-209.76-187.55-192.27-97.33246.34
Net Cash Growth
------11.88%
Net Cash Per Share
-0.65-0.84-0.75-0.76-0.381.00
Filing Date Shares Outstanding
240.72253.03253.03253.03252.62252.08
Total Common Shares Outstanding
240.72253.03253.03253.03252.44252.08
Working Capital
285.63171.5337.7535.77324.31599.5
Book Value Per Share
7.567.046.876.756.526.36
Tangible Book Value
1,5961,5721,5221,4841,4891,453
Tangible Book Value Per Share
6.636.216.025.875.905.76
Buildings
-1,009932.34931.6449.85398.83
Machinery
-1,095943.65929.21474.19443.58
Construction In Progress
-37.4203.8175.14704.43315.72